Paragonix Technologies today announced positive long-term registry results demonstrating improvements after heart transplantation. Results from the GUARDIAN-Heart registry demonstrated statistically significant improvements in 2-year survival following heart transplantation. The analysis consisted of a total of 1,261 U.S. adult patients matched using statistical propensity matching. This created two cohorts of equal baseline characteristics to compare the […]
Paragonix Technologies
Paragonix begins full U.S. launch of donor lung preservation system
Paragonix Technologies announced today that it began the full commercial launch of its Baroguard donor lung preservation system. Baroguard, a first-of-its-kind system, offers an alternative to the current practices. These practices see donor lungs preserved and transported from an inflated state between donor and recipient. Those current organ recovery techniques fail to reliably maintain and […]
Paragonix announces first human use of donor lung preservation system
Paragonix Technologies announced today that it successfully completed the first-in-human case using its new donor lung preservation technology. Waltham, Massachusetts-based Paragonix received FDA clearance for the BAROguard donor lung preservation system in August. It offers an alternative to the current practices. These practices see donor lungs preserved and transported from an inflated state between donor […]
Organ transplant tech developer Paragonix opens new U.S. HQ
Paragonix Technologies announced today that it opened its new corporate headquarters in Waltham, Massachusetts. The organ transplant tech company says its expansion reflects continued growth and its commitment to serving clinicians and patients worldwide. Paragonix’s facility features state-of-the-art R&D laboratories and collaborative spaces. It aims to foster innovation and teamwork across departments in the evolving […]
Paragonix wins FDA clearance for next-gen lung preservation system
Paragonix Technologies announced today that the FDA granted clearance for its next-generation BAROguard donor lung preservation system. BAROguard combines Paragonix’s existing advanced hypothermic preservation technology with automated continuous and active airway pressure control. This ensures that the system maintains an optimal temperature range and a clinically recommended inflation pressure range. It maintains this for donor […]
Study backs Paragonix lung preservation system
Paragonix Technologies announced today that study data demonstrated favorable outcomes related to its LUNGGuard organ preservation system. Cambridge, Massachusetts–based Paragonix evaluated its LUNGGuard against conventional ice-cold storage. The study used real-world, multi-center data collected from the GUARDIAN-Lung Registry. This analysis demonstrated a favorable influence from advanced lung preservation technology on post-transplant outcomes. Paragonix said it […]
Organ preservation tech developer Paragonix raises $24M series B
Paragonix Technologies announced today that it secured $24 million in a Series B financing round. Cambridge, Massachusetts-based Paragonix plans to use the funds to bolster its commercial footprint. That includes the ongoing extension of its clinical service offerings and inventory expansion. The company also plans to use funds to further advance its organ transplant innovations. […]
Paragonix reaches milestone of 2,000 organs preserved, transported for transplantation
Paragonix Technologies announced today that it has preserved more than 2,000 donor organs for transport and transplantation. Cambridge, Massachusetts–based Paragonix designed its devices to combine clinically proven, stable, hypothermic preservation technology with an extensive clinical support network. There are digital tools for complete control over the process of organ tracking, monitoring and reporting. “We are […]
Paragonix launches lung preservation and transport system
Paragonix Technologies announced today that it launched its LUNGguard donor lung preservation system in the U.S. and Europe. Cambridge, Mass.–based Paragonix designed the LUNGguard for the hypothermic preservation of lungs during transportation and the eventual transplantation into a recipient using cold storage solutions. LUNGguard is indicated for a storage time of up to eight hours, […]
FDA clears Paragonix donor lung preservation system
Paragonix Technologies announced today that it won FDA 510(k) clearance for its LUNGguard donor lung preservation system. Paragonix designed the LUNGguard for the hypothermic preservation of lungs during transportation and the eventual transplantation into a recipient using cold storage solutions. LUNGguard is indicated for a storage time of up to eight hours. Cambridge, Mass.–based Paragonix’s […]
Paragonix launches SherpaPak pancreas transport system in U.S.
Paragonix Technologies today announced the FDA clearance and U.S. launch of its SherpaPak pancreas transport system, which the company says is able to provide “unprecedented thermal and physical protection” during the transportation of donor pancreases slated for people with diabetes. “The donor pancreas is highly susceptible to cold and compression injury during transport. Technologies that […]